Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Michael M. Goldberg currently holds 5,921,023 shares of NAVIDEA BIOPHARMACEUTICALS, INC. (NAVB), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Michael M. Goldberg has been a net buyer of NAVB stock. They have purchased $107.7K and sold $0 worth of shares.
Michael M. Goldberg's most recent insider trade was on May 16, 2017, when they sold 106,021 shares at $0.46 per share.
Michael M. Goldberg serves as Executive at NAVIDEA BIOPHARMACEUTICALS, INC. (NAVB). They have executed 19 insider transactions totaling $107.7K over their tenure at the company.
Michael M. Goldberg holds the position of Executive at NAVIDEA BIOPHARMACEUTICALS, INC., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Michael M. Goldberg has shown a buying trading pattern, with $107.7K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Michael M. Goldberg was on Dec 19, 2006, when they purchased $102.0K worth of EMIS shares. This transaction involved 20,000 shares at $5.10 per share.
Michael M. Goldberg currently owns 5,921,023 shares of NAVIDEA BIOPHARMACEUTICALS, INC. (NAVB), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Michael M. Goldberg's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Michael M. Goldberg has 19 Form 4 filings on record as an insider at NAVIDEA BIOPHARMACEUTICALS, INC..
Set alerts for Michael M. Goldberg and 40,000+ other insiders.